Vania Modesto-Lowe, MD, MPH

Quinnipiac University Health Sciences, Hamden, Connecticut

PCC
Fentanyl Test Strips and Drug Use Modification
Letter to the Editor

May 14, 2024

The authors explore the use of fentanyl test strips as a harm reduction tactic to identify contaminated substances for people who use illicit drugs.
, ,
PCC
Do Not Overlook Bupropion Misuse
Letter to the Editor

April 30, 2024

Jasleen Kaur, MD, and colleagues comment on a case report published in the PCC.
, ,
PCC
Deprescribing Benzodiazepines: Is Harm Reduction Enough?
Letter to the Editor

December 28, 2023

Vania Modesto-Lowe, MD, MPH, and Claire N. Aurilio, BS, comment on a recent publication in the PCC.
,
PCC
Social Determinants of Health and Extended-Release Naltrexone
Brief Report

June 29, 2023

Patients with alcohol use disorder are at high risk of treatment nonadherence and readmission. While ER naltrexone can help prevent relapse for 28 days, they may face homelessness for...
,
PCC
Buprenorphine Maintenance in the Fentanyl Era
Letter to the Editor

February 14, 2023

Methods to foster patient adherence and physician acceptability of buprenorphine maintenance are needed to incorporate this treatment into primary care for fentanyl users.
,
PCC
Mindfulness Training in Opioid Withdrawal
Letter to the Editor

June 30, 2022

In this letter to the editor, the authors comment on an article published recently in the PCC.
, ,
PCC
The Hidden Curriculum in Addiction Training
Letter to the Editor

March 24, 2022

In this letter to the editor, the authors discuss the stigma associated with addiction treatment, as well as strategies to increase addiction literacy among physicians.
,
JCP
Letter to the Editor

July 27, 2021

This Letter to the Editor comments on two recent Journal articles that discuss coping responses and resilience among health care workers during the COVID-19 pandemic.
, ,

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe